Homology Medicines, Inc.

NAS:FIXXHealthcare

$9.98+4.36%At closeAt close · Mon 19 Oct · ≈ AED 36.65 · Market cap $140.67M

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	−3,615.5%	71.9%	19.0%	50.0%	—	—	—	—
Operating margin	−4,821.0%	−282.4%	−4,154.6%	−7,967.3%	—	—	—	—
Net margin	−4,704.8%	−281.4%	−156.0%	−9,771.7%	—	—	—	—
EBITDA margin	−4,526.2%	−257.9%	−4,114.3%	−7,917.3%	—	—	—	—
Return on equity	−64.9%	−56.3%	−2.8%	−154.8%	−841.1%	71.0%	71.0%	+0.0 pts
Return on assets	−48.2%	−45.1%	−2.2%	−36.9%	−51.7%	48.3%	48.3%	+0.0 pts
Return on capital employed	−54.0%	−49.3%	−64.7%	−31.3%	−87.1%	33.5%	—	—
Debt / equity	0.1×	0.1×	0.2×	0.0×	1.5×	0.3×	0.3×	+0.0%
Debt / assets	5.9%	11.3%	12.9%	0.4%	9.5%	18.1%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	9.7×	11.1×	8.0×	7.3×	5.0×	4.9×	4.9×	+0.0%
Quick ratio	9.7×	11.1×	8.0×	7.3×	5.0×	4.9×	—	—
Cash ratio	9.6×	6.3×	1.5×	3.4×	4.7×	4.3×	4.3×	+0.0%
Asset turnover	0.0×	0.2×	0.0×	0.0×	0.0×	0.0×	—	—
Receivables turnover	6.8×	—	—	—	—	—	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.